Clostridioides difficile, formerly known as Clostridium difficile, is a bacterium notorious for causing severe gastrointestinal infections, often in healthcare settings. This resilient pathogen thrives in environments altered by antibiotic use, disrupting the balance of gut microbiota and allowing C. difficile to proliferate and produce toxins. The resulting infection, known as C. difficile-associated disease (CDAD), manifests as diarrhea, abdominal pain, and, in severe cases, life-threatening complications such as pseudomembranous colitis and toxic megacolon. Managing CDAD poses significant challenges due to the bacterium's ability to form resilient spores, making it resistant to many standard disinfection methods. Prevention and control strategies, including stringent hand hygiene practices, judicious antibiotic use, and environmental decontamination, are essential for combating C. difficile infections and reducing their impact on patient outcomes and healthcare systems.